Related Experiment Video

Updated: Aug 8, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.2K

Erratum to: Prognostic Factors for Survival in Patients with Carcinoma Endometrium

Aparna Mullangath Prakasan1, Minolin Dhas1, Krishnapillai M Jagathnathkrishna2

  • 1Department of Radiation Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India.

South Asian Journal of Cancer
|February 28, 2023
PubMed

Abstract:

[This corrects the article DOI: 10.1055/s-0041-1735563.].

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

318
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Experiment Videos

Last Updated: Aug 8, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

318
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

408
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
408
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

212
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
212

Articles linked to this work by shared authors, journal, and citation graph.

HMGB1-targeted anti-inflammatory rBox A gene therapy for viral airway infections and systemic inflammatory disease models.

mBio·2026

Consensus Building for Radiotherapy Quality Assurance: A Multicenter Methodological Narrative From India (Standardised Unified Radiotherapy Quality Assurance).

JCO global oncology·2026

Safety and Effectiveness of Two Reconstitution Volumes of Poly-L-Lactic Acid for Correction of Décolletage Wrinkles.

Journal of drugs in dermatology : JDD·2026

Continuous production of recombinant adeno-associated virus in the insect cell/baculovirus expression vector system.

Molecular therapy. Advances·2026

Predicting radiology no-shows with machine learning: Methodological pitfalls and practical considerations.

Current problems in diagnostic radiology·2026

3D Bioprinting of Continuous Nanofibrous Yarn-Reinforced Cell-Laden Constructs.

ACS applied bio materials·2026

Corrigendum: Long-Term Outcomes of Thymoma Treated at a Single Institute.

South Asian journal of cancer·2026

Spindle Cell Variant of Rhabdomyosarcoma: An Aggressive Clinical Case of the Oral Cavity.

South Asian journal of cancer·2025

Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India.

South Asian journal of cancer·2025

Retrospective Outcome Analysis of Allogenic Bone Graft.

South Asian journal of cancer·2025

Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India.

South Asian journal of cancer·2025

Comparative Analysis of Surgical Site Infections in Pediatric Brain Tumor Patients: Hygiene Practices, Risk Factors, and Implications for Healthcare Costs and Mortality.

South Asian journal of cancer·2025
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us